ESMC · Escalon Medical Corp
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company’s ability to continue as a going concern for the twelve months following issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed May 15, 2026
Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
|
2026-07-31
Scheduled
FINRA publishes Aug 11
|
— | — | — | — |
| 2026-07-15 | 82,923 | 82,923 | 0 | 7.06 |
| 2026-06-30 | 82,923 | 83,822 | -899 | 16.73 |
| 2026-06-15 | 83,822 | 83,822 | 0 | 4.16 |
| 2026-05-29 | 83,822 | 171,227 | -87,405 | 1.00 |
| 2026-05-15 | 171,227 | 15 | +171,212 | 2.04 |
| 2026-04-30 | 15 | 15 | 0 | 1.00 |
| 2026-04-15 | 15 | 5 | +10 | 1.00 |
| 2026-03-31 | 5 | 5 | 0 | 1.00 |
| 2026-03-13 | 5 | 5 | 0 | 1.00 |
| 2026-02-27 | 5 | 0 | +5 | 1.00 |
| 2025-09-15 | 132 | 80 | +52 | 1.00 |
| 2025-08-29 | 80 | 80 | 0 | 1.00 |
| 2025-08-15 | 80 | 80 | 0 | 1.00 |
| 2025-07-31 | 80 | 144 | -64 | 1.00 |